The COVID-19 pandemic presents two main concerns for patients with myasthenia gravis (MG); chronic immunosuppression may put them at greater risk, and some proposed treatments for COVID-19 could cause MG exacerbation.
from Journal of the Neurological Sciences https://ift.tt/39lHjjO
from Journal of the Neurological Sciences https://ift.tt/39lHjjO
Comments
Post a Comment